Investigating how a protein affects vision in diabetes-related eye disease
Redox-sensitive activation of REDD1 in diabetic retinopathy
This study is looking at how a protein called REDD1 affects eye health in people with diabetes, and it's trying to find new ways to protect vision by reducing the damage caused by this protein, which could lead to better treatments for diabetic retinopathy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project ID | NIH-10999311 on NIH RePORTER |
What this research studies
This research focuses on the role of a protein called REDD1 in the development of diabetic retinopathy, a condition that can lead to vision loss in people with diabetes. The study aims to explore new therapeutic strategies to prevent retinal damage by targeting the mechanisms that increase REDD1 levels in the retina. By understanding how REDD1 functions as a redox sensor, researchers hope to identify ways to mitigate its harmful effects on vision. Patients may benefit from innovative treatments that could improve visual function and prevent disease progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are at risk of developing or are already experiencing diabetic retinopathy.
Not a fit: Patients without diabetes or those with advanced proliferative diabetic retinopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help preserve vision in patients with diabetic retinopathy.
How similar studies have performed: Previous research has shown some success with targeting REDD1, but this approach is being revisited with new insights into its role in retinal disease.
Where this research is happening
Hershey, United States
- Pennsylvania State Univ Hershey Med Ctr — Hershey, United States (Active)
Researchers
- Principal investigator: Dennis, Michael D. — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Dennis, Michael D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.